|
|
||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||

T Cells Changes with Exposure to Inhaled Ovalbumin







*Integrated Department of Immunology, National Jewish Health, Denver, CO 80206;
University of Colorado, Denver, CO 80206; and
Department of Medicine, National Jewish Health, Denver, CO 80206
It has been reported that the IgE response to allergens is influenced by 
T cells. Intrigued by a study showing that airway challenge of mice with OVA induces in the spleen the development of 
T cells that suppress the primary IgE response to i.p.-injected OVA-alum, we investigated the 
T cells involved. We found that the induced IgE suppressors are contained within the V
4+ subset of 
T cells of the spleen, that they express V
5 and CD8, and that they depend on IFN-
for their function. However, we also found that normal nonchallenged mice harbor IgE-enhancing 
T cells, which are contained within the larger V
1+ subset of the spleen. In cell transfer experiments, airway challenge of the donors was required to induce the IgE suppressors among the V
4+ cells. Moreover, this challenge simultaneously turned off the IgE enhancers among the V
1+ cells. Thus, airway allergen challenge differentially affects two distinct subsets of 
T cells with nonoverlapping functional potentials, and the outcome is IgE suppression.
Address correspondence and reprint requests to Dr. Willi K. Born, Integrated Department of Immunology, National Jewish Health, 1400 Jackson Street, GB K409, Denver, CO 80206. E-mail address: bornw{at}njc.org
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |